Investment Summary |
|
---|---|
Date | 2021-01-06 |
Target | Amp Solar Group |
Sector | Renewable Energy |
Investor(s) | The Carlyle Group |
Deal Type | Growth Capital |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 1987 |
PE ASSETS | 435.0B USD |
Size | Mega |
Type | Sector Agnostic |
The Carlyle Group is a global investment firm that pursues private equity, credit, and real estate investments worldwide. Carlyle's private equity practice practice pursues buyouts, strategic minority equity investments, equity private placements, consolidations and buildups, and growth capital financings. With offices in 19 countries, Carlyle can easily target opportunities throughout North America, Europe, Asia, Australia, the Middle East/North Africa and Latin America. Broad sectors of interest include aerospace, defense, automotive and transportation, consumer, retail, energy and power, financial services, healthcare, industrial, infrastructure, technology services, business services, telecommunications and media. The Carlyle Group was formed in 1987 and is based in Washington DC.
DEAL STATS | # |
---|---|
Overall | 690 of 742 |
Sector (Renewable Energy) | 7 of 7 |
Type (Growth Capital) | 108 of 113 |
State (Ontario) | 4 of 4 |
Country (Canada) | 8 of 8 |
Year (2021) | 3 of 28 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-01-06 |
Rigaku
Tokyo, Japan Rigaku is a provider of analytical and industrial instrumentation technology. Rigaku offers general X-ray diffraction, thin-film analysis, X-ray fluorescence spectrometry, small-angle X-ray scattering, protein and small molecule X-ray crystallography, Raman spectroscopy, X-ray optics, semiconductor metrology, X-ray sources, computed tomography, non-destructive testing, and thermal analysis. Rigaku was founded in 1951 and is based in Tokyo, Japan. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-01-08 |
Abbisko Therapeutics
Shanghai, China Abbisko Therapeutics is an oncology focused biopharmaceutical company dedicated to the discovery and development of innovative medicines for unmet medical needs in China and around the world. Abbisko Therapeutics was founded in 2016 and is based in Shanghai, China. |
Buy | - |